Bioengineered mesenchymal stem cell-derived exosomes: emerging strategies for diabetic wound healing

Area of Science:

• Regenerative Medicine
• Biotechnology
• Diabetes Complications

Background:

• Diabetic wounds present significant challenges due to impaired healing mechanisms.
• Mesenchymal stem cell-derived exosomes (MSC-Exos) show therapeutic promise but face limitations like poor targeting and low yield.
• Bioengineering offers solutions to enhance MSC-Exos efficacy and production for clinical use.

Purpose of the Study:

• To review the role of MSC-Exos in diabetic wound healing.
• To summarize bioengineering strategies for enhancing MSC-Exos.
• To discuss the application and future prospects of bioengineered MSC-Exos.

Main Methods:

• Review of literature on MSC-Exos and bioengineering techniques.
• Focus on three bioengineering strategies: parental MSC-Exos engineering, direct MSC-Exos engineering, and MSC-Exos combined with biomaterials.
• Analysis of the application of bioengineered MSC-Exos in diabetic wound healing.

Main Results:

• MSC-Exos possess inherent therapeutic properties beneficial for diabetic wound healing.
• Bioengineering significantly improves MSC-Exos targeting, concentration, retention, and yield.
• Engineered MSC-Exos demonstrate enhanced efficacy in preclinical models of diabetic wound healing.

Conclusions:

• Bioengineered MSC-Exos represent a promising therapeutic strategy for accelerating diabetic wound healing.
• Further research into bioengineering techniques will optimize MSC-Exos for clinical translation.
• Addressing challenges in yield and targeting is crucial for the widespread application of MSC-Exos therapy.